Ivermectin requirements

Systemic reactions are less severe than with diethylcarbama2ine. The most commonly seen reactions are fever, rash, and lymph-node pain or swelling. Suppressive ivermectin therapy consists of a single oral dose every 6—18 months. The required duration of suppressive therapy is unknown, probably at least three years (36). Ivermectin is available from the CDC Dmg Service on request. It is manufactured by Merck Sharp and Dohme in the United States and England. 

Since the avermectins exhibit unprecedented potency, they are used at unusually low doses of 6 —300 )-lg/kg, which makes the detection and isolation of residues and metaboUtes from animal tissue a new challenge. For this reason a sensitive analytical assay requires a derivative suitable for detection at concentrations down to 1/10 or 1/100 of one ppm. Ivermectin and avermectin B are therefore converted into an aromatic derivative which allows detection by fluorescence absorbance. To achieve this derivatization, avermectin B, ivermectin, or their derivatives are heated with acetic anhydride in pyridine at 100°C for 24 h (30). The reaction time can be reduced to 1 h by using /V-methylimidazole as a catalyst (31). The resultant... 

When CNS involvement occurs, the poor penetration of suramin and pentamidine into the CSF requires alternative forms of chemotherapy, such as melarsoprol in combination with suramin. In treating Onchocerca volvulus infections, suramin kills adult worms and is an alternative to ivermectin. Suramin is used after initial treatment with diethylcarbamazine, which is used to kill the microfilariae. It produces favorable results in pemphigus and prolongs the time to disease progression in hormone-refractory prostate cancer. 

Antihistamines may be given for the first few days of therapy to limit allergic reactions, and corticosteroids should be started and doses of diethylcarbamazine lowered or interrupted if severe reactions occur. Cures may require several courses of treatment. For patients with high L loa worm burdens (more than 2500 circulating parasites/mL), strategies to decrease risks of severe toxicity include apheresis, if available, to remove microfilariae before treatment with diethylcarbamazine or therapy with albendazole, which is slower acting and better tolerated, before therapy with diethylcarbamazine or ivermectin. 

Unfortunately, protozoan flagellates like trypanosomes are unaffected by ivermectin (21) but, at least, the animals that take up the ivermectin (with coccidiostat) will be rid of most gastrointestinal nematodes and ectoparasites. Gxtraintestinal filariasis can also be treated for example, microfilarial dermatitis in horses (22) and even onchocerciasis in humans (23). which is transmitted by the bite of infected black flies (Slmulium spp.). However, the doses required (30 - 50 pg/kg) in the latter case were not without short term side effects. 

The efficacy and adverse effects of ivermectin 200 micro-grams/kg, repeated 2 weeks later, have been stndied in 50 patients with chronic strongyloidiasis, aged 30-79 years (13). The eradication rate was 96% at 2 weeks after the first dose and 98% after the second dose. There was no recurrence after follow-up of 4 months. One patient had nausea and vomiting 3 hours after the first dose and again after the second dose, but they were transient and required no therapy. In four patients there were mild laboratory abnormalities (slight increases in liver function tests in two, microscopic hematuria in one, and mild leukopenia and lymphocytosis in one). Of the 50 patients 12 were positive for human T lymphotropic virus type-I. 

For maximum precision and reproducibility, we found that it was necessary to incubate the standards and unknowns with the MAb for at least 2 hr at room temperature before the mixtures were added to the coated EIA wells. The dose-response curve of the EIA was between 1 and 100 ppb for ivermectin, abamectin, and the other analogs and metabolites described below. We did not determine the ultimate detection limits of the procedures for abamectin residues in water or strawberry homogenate. However, we recovered as little as 0.1 ppb of abamectin in water with s90% efficiency by the procedure described. The assay is extremely economical each sample well is coated with ivermectin-carrier conjugate containing about 25 ng of carrier protein, and each sample requires only 0.5 to 1 pi of MAb in filtered hybridoma culture medium. 

Adverse reactions accompanying the first administration of ivermectin occurred in nine patients (7.2%), and included dizziness (2.4%), nausea (1.6%), and diarrhea (1.6%). Each of these adverse reactions was mild and transient and none required particular treatment. After the second administration, adverse reactions occurred in five patients (4.0%), but this frequency was lower and adverse reactions were mild and transient. Mazzotti-type reactions associated with the treatment of onchocerciasis did not occur in these patients with strongyloidiasis treated with ivermectin (Table VI). 

Low test doses are used, often with glucocorticoid or antihistamine pretreatment to minimize reactions to dying microfilariae and adult worms. Repeated courses of diethylcarbamazine treatment, separated by 3—4 weeks, may be required. Ivermectin is not a good alternative for treatment of... 

LC-PB-MS has been investigated as a potential confirmatory method for the determination of malachite green in incurred catfish tissue, " and cephapirin, furo-semide, and methylene blue in milk, kidney, and muscle tissue, respectively. LC-PB-MS has also been investigated for the analysis of ivermectin residues in bovine hver and milk. The specificity required for regulatory confirmation was obtained by monitoring the molecular... 

---